News | News By Subject | News by Disease News By Date | Search News

News By Date

Get Our FREE
Industry eNewsletter
News By Date


Monday, August 31, 2015

Top Breaking News
Bristol-Myers Squibb (BMY) Bags Rights to Buy Promedior in Deal Worth $1.25 Billion
Amicus (FOLD) Snaps up Scioderm and its Lead EB Drug in Deal Worth $847 Million
Pfizer (PFE) Expected to Terminate a Large Number of Employees in Korea
Baxalta Rumored to Acquire Ariad (ARIA) to Strengthen Oncology
Biopharma Crystal Ball: Four (or Five) Possible Acquisition Targets
South San Francisco's CytomX Files for $100 Million IPO
Google (GOOG)'s Life Sciences to Partner with Sanofi (SNY) on Diabetes Therapies and Monitors
Bayer (BAY) Moves to Phase III Studies After Finerenone Cuts Deaths in Mid-Stage Trial
Alnylam (ALNY), The Medicines Company (MDCO)'s Long-Acting Cholesterol Drug May Threaten Amgen (AMGN), Regeneron (REGN)-Sanofi (SNY)'s Blockbusters
NeuroVive Discontinues Ciclomulsion for Myocardial Infarction
TiGenix's Cx601 Meets Primary Endpoint in Phase III Study

News from Around the Web
Myth Debunked: You Can Build Passion For Your Job, University of Michigan Study
Why Women Are More Likely To Ask For A Divorce, Stanford University Study
Midday Naps At The Office Linked To Lower Blood Pressure, Asklepieion Voula General Hospital Study
Coffee Ups Heart Attack and Diabetes Risk In Young People, Hospital Of San Daniele del Friuli Study
Food May Be Addictive, Monash University Study Shows
Why We Find It Hard To Keep Track Of Days Of The Week, University Of Lincoln Study
Ice Cream That Does Not Melt "Could Soon Hit The Shelves," University of Dundee Reveals
Ant-Man's Bad Biology Defeated Good Science. Can We Save Superhero Movies?
Sanofi (SNY), AstraZeneca PLC (AZN)’s Unique Benefit Programs
Could Oral Contraceptives Help Ease Rheumatoid Arthritis? Rheumatism Research Centre Study
From Science Fiction To Reality - The Dawn Of The Biofabricator
Mouth Guard Monitors Health Markers, Transmits Information Wirelessly To Smart Phone, University of California, San Diego (UCSD) Study
This Diagnostics Lab In India Has Come Up With A Unique Test To Treat Septicemia
Study Says Tiny Wireless Pacemaker OK, But Doctors Cite Safety Concerns
Synthetic Heart Tissue Sticks Like Velcro, University of Toronto Study

Press Releases
Bristol-Myers Squibb (BMY) and QIMR Berghofer Medical Research Institute Forge Pact to Discover New Immuno-Oncology Antibodies
Resverlogix (RVX.TO) Presents New Data At The European Society of Cardiology Congress 2015 On RVX-208 'Apabetalone' A Selective BET Inhibitor
Piramal Imaging Announces Publication Of Phase III Neuraceq (florbetaben F18) PET Imaging Data In Alzheimer's & Dementia
TWi Pharmaceuticals, Inc. President & CEO Ms. Tina Guilder Will Resign From Her Current Roles And Chairman Dr. Chih-Ming Chen Will Become Interim President & CEO, Leading The Company In Its Continued Efforts To Develop High-Entry-Barrier Generics For The U.S. Market
Ascletis, Inc. Phase II Clinical Trial Of Its Interferon-Free HCV Regimen In Taiwan
Soligenix (SNGX) Announces Completion Of Patient Enrollment Into Its Phase 2 Clinical Trial Of SGX942 For The Treatment Of Oral Mucositis In Head And Neck Cancer Patients (1)
Asterias Biotherapeutics Concludes Recruitment Of Initial Safety Cohort Of The SCiStar Phase 1/2a Dose-Escalation Clinical Trial Of AST-OPC1 For Complete Cervical Spinal Cord Injury
MicuRx Pharmaceuticals Reports Positive Top-Line Results In Phase 2 Clinical Trial For Novel Antibiotic MRX-I In Complicated Skin And Soft Tissue Infections
RXi Pharmaceuticals (RXII) Announces Advancements In Its Ophthalmology Clinical Program With RXI-109
Novogen Limited (NVGN) Announces The Outcome Of A Comprehensive Science Review
Ipsen (IPN.PA) Announces The Lancet Neurology Publishes Dysport Phase III Registration Trial Results In Adult Patients With Upper Limb Spasticity (ULS)
Ipsen (IPN.PA) Announces Publication In The Lancet Neurology Of The Results Of The Phase III Randomized Study (NCT01313299) Showing Efficacy And Safety Of Dysport (Abobotulinumtoxina) In Adult Patients With Upper Limb Spasticity (ULS)
Alnylam (ALNY) Release: ALN-PCSsc Achieves Quarterly And Potentially Bi-Annual Subcutaneous Dose Regimen Profile For Effective LDL-C Lowering In Phase 1 Clinical Study
Alnylam (ALNY) And The Medicines Company (MDCO) Release: ALN-PCSsc Achieves Quarterly And Potentially Bi-Annual Subcutaneous Dose Regimen Profile For Effective LDL-C Lowering In Phase I Clinical Study
Sunovion Pharmaceuticals Inc. Announces FDA Approval Of A New Indication For Aptiom (Eslicarbazepine Acetate) As Monotherapy For Partial-Onset Seizures
Sun BioPharma Announces U.S. FDA Grants IND For SBP-101 Pancreas Special Effect First in-Class Compound
Titan Pharmaceuticals (TTP) Announces Resubmission Of The New Drug Application For Probuphine For The Maintenance Treatment Of Opioid Addiction
Great Basin Scientific Submits 510(K) Application To The FDA For Staph ID/R Blood Culture
Telesta Receives FDA BLA Filing Notification Letter And Priority Review Designation For MCNA(1)
FDA Grants Priority Review For Intercept Pharma (ICPT)'s Obeticholic Acid For The Treatment Of Primary Biliary Cirrhosis
Lipocine Inc. (LPCN) Submits New Drug Application To FDA For Its Oral Testosterone Replacement Product Candidate, LPCN 1021
Atara Biotherapeutics (ATRA) Announces Completion Of Enrollment In PINTA 745 Phase II Clinical Trial In End-Stage Renal Disease Patients With Protein Energy Wasting
OncoMed Pharmaceuticals, Inc. (OMED) Completes Enrollment Of Phase II ALPINE Clinical Trial Of Tarextumab In Pancreatic Cancer
Corbus Commences Patient Enrollment In Phase 2 Clinical Study Of Resunab For The Treatment Of Systemic Sclerosis
Portage Biotech's PPL Will Advance Its Lead Candidate PPL-003 To An IND For Dry Eye Disease And Uveitis
Bionomics Limited (BNO.AX) Release: Successful BNC101 IND Submission Paves Way For Development Of Promising Cancer Stem Cell Drug Candidate
Biolight Reports Positive Clinical Study Results For Identifying New Genetic Markers To Predict Risk Of Developing BRONJ
MIT Release: Possible New Weapon Against PTSD
St. Jude Medical (STJ) Release: Five Year Data From The FAME Trial Further Confirms The Sustained, Long Term Benefit Of FFR-Guided PCI Over Angiography-Guided Intervention
IM HealthScience Release: Results Of Confirmatory Clinical Trial Presented At The American Gastroenterological Association's (AGA) Freston Conference Support IBgard As A New Approach In Managing Irritable Bowel Syndrome (IBS)
Therapeutic Solutions International Acquires Preterm Labor And Miscarriage Intellectual Property From OmniBiome Therapeutics
Allergan (AGN) Successfully Completes Naurex Acquisition
Perrigo (PRGO) Acquires Leading U.S. Scar Management Brand ScarAway
Eisai Company (ESALY.PK) And Purdue Pharma L.P. Enter Worldwide Collaboration To Develop And Commercialize Lemborexant
Celyad Announces Commercial License Agreement for C-Cure In Greater China
Endo Pharmaceuticals (ENDP) Announces XIAFLEX For Dupuytren's Contracture Formal Pricing In Japan; Commercial Launch Set For September 16, 2015
AMRI (AMRI) Announces Agreement With Saneca Pharmaceuticals, a.s. For Portfolio Of Opium-Derived Active Pharmaceutical Ingredients
ESC Launches New Concept For Driving Innovation In Cardiovascular Research With Exclusive Support From Boehringer Ingelheim
AxioMx Receives SBIR Grant For DNA-Protein Complex Antigen Development
BioSpecifics Technologies Corporation (BSTC) Announces Formal Pricing Of XIAFLEX For The Treatment Of Dupuytren's Contracture In Japan
Regen BioPharma Develops BORIS Gene Silencing Based Treatment For Unresectable Liver Cancer
Qu Biologics Opens Additional Ulcerative Colitis Clinical Trial Sites In Edmonton And Hamilton
Shanghai Pharmaceutical Co., Ltd. To Form $470 Million China Healthcare VC Fund
Mount Tam Biotechnologies To Be Traded Under The Symbol OTCBB:MNTM
Amyris, Inc. Achieves Breakthrough Performance With 2nd Fragrance Molecule Ready For Industrial Scale Fermentation In Less Than 12 Months
Hemispherx Biopharma (HEB) Fully Aligns Executive Bonus Programs To Accelerate Product Revenue Opportunities And Market Entry
Stellar Biotechnologies, Inc. Announces Reverse Stock Split In Preparation For Proposed Uplisting To NASDAQ Capital Market
Texas Back Institute Surgeon Adopts Pediguard With Dynamic Surgical Guidance (DSG) Technology, SpineGuard’s Device Designed To Help Make Spine Surgery Safer
Applied Photophysics Release: Established UK Company Chooses Beverly For Its First North American Facility
Phenomenex, Inc. Adds New Lux Amylose-1 Chiral Stationary Phase For HPLC And SFC Analysis And Purification Work
Mainstay Medical (MSTY.PA) Announces Half Year Financial Results
Lion Biotechnologies, Inc. Announces Strategic Hires
Cold Chain Technologies Appoints Mark S. Davis Director of Global Logistics Services
FLX Bio Announces Senior Management Hires And Initiation Of Phase 1 Trial Of FLX925
Ocata Therapeutics Appoints Dr. Brian Levy To Its Board Of Directors
The Medicines Company (MDCO) Appoints Dr. Fred Eshelman As Non-Executive Chairman Of The Board
Kaleo Release: More than 100 Lives Reported Saved Since Launch Of The "kaleo Cares" EVZIO® (naloxone HCl injection) Donation Program
The Leukemia & Lymphoma Society's Light The Night Walk Teams: Powerful Partnerships That Help Save Lives
The National Parkinson Foundation's Medical Director Publishes New Book On Breakthrough Therapies For Parkinson's Disease
Proof Of Impact: The Leukemia & Lymphoma Society Is Making Progress Toward A World Without Blood Cancers
iQ3Corp Ltd (ASX:IQ3) App 4E / Full Year Statutory Accounts
Critical Path Institute’s Polycystic Kidney Disease Outcomes Consortium Secures FDA Qualification For Enrichment Biomarker In Autosomal Dominant Polycystic Kidney Disease (ADPKD)
GraftWorx Wins Preclinical In-Kind Services From Surpass, Inc. As Part Of The Rosenman Institute's 2015 Innovation Award
Epizyme (EPZM) To Present At Upcoming Events In September
InVivo Therapeutics (NVIV) To Present At 2015 Tissue Engineering & Regenerative Medicine International Society World Congress
Eleven Biotherapeutics (EBIO) To Present At NewsMakers In The Biotech Industry Conference
NephroGenex (NRX) To Participate In Two Healthcare Conferences In September
MabVax Therapeutics, Inc. HuMab 5B1 Antibody Is Highlighted At Upcoming World Molecular Imaging Congress In Five Separate Presentations
ERT To Demonstrate Innovation Lab Prototypes At European PRO / eCOA Congress
BioMarin (BMRN) Announces Two Oral And 19 Poster Presentations At The Society For The Study Of Inborn Errors Of Metabolism 2015 Annual Meeting
Vital Therapies (VTL) Announces Additional Data From VTI-208 Presented At Rostock Conference
Dipexium Pharmaceuticals (DPRX) Announces Participation In Four Investor Conferences In September
Phase II Study Of Advaxis, Inc.'s Axalimogene Filolisbac (ADXS-HPV) In Cervical Cancer To Be Presented At 2015 AGOS Annual Meeting
Mettler-Toledo (MTD) Hosts Food Safety Educational Center At 2015 PROCESS EXPO
Regeneron (REGN) Announces Upcoming 2015 Investor Conference Presentations
BeyondSpring To Present Two Posters Supporting Plinabulin At WCLC 2015
Week In Review: Hepalink Pharma Buys US-Based CMO Cytovance
Insulet (PODD) Recalls More Than 400,000 OmniPods
Medtronic (MDT) Identifies Gene Associated with Sudden Cardiac Death
ConforMIS Initiates Voluntary Recall of iUni, iDuo and iTotal Systems
Integrity Applications Receives CE Mark Approval For Multiple Improvements To GlucoTrack Model DF-F
Bayer (BAY) Opens First Medical Device Plant in Costa Rica
Vention Medical Opens Up Shop in Israel
Perseon Announces The Initiation Of The First Multi-Organ In Vivo Ablation Zone Study For Microthermx In Laparoscopic And Open Approaches
Mitralign, Inc. Receives FDA Approval For Percutaneous Tricuspid Repair Early Feasibility Study
NeuroMetrix (NURO) Reports Positive Pilot Data For Use Of Its Wearable Pain Relief Technology In Restless Leg Syndrome
Sunshine Heart Announces FDA Approves Key Protocol Amendment For COUNTER HF US Pivotal Study For C-Pulse Heart Assist System
St. Jude Medical (STJ) Release: LEADLESS II Trial Results Published In The New England Journal of Medicine Confirm The Positive Benefits Of The Nanostim Leadless Pacemaker
IlluminOss Medical Inc.'s First-of-Its-Kind Bone Stabilization System Used In Treatment Of Rhode Island Hospital Patient
Positive Results For Mainstay Medical (MSTY.PA)’s Clinical Trial Of ReActiv8
BIOTRONIK Announces First Patient Enrolled In BIOFLOW-VI Clinical Study In China
The Female Health Company Receives Orders For 15 Million FC2 From Brazil
Daktari Enters Collaboration Agreement With Merck & Co. (MRK) To Develop Test For Hepatitis C Virus
CenterVue Launches COMPASS Fundus Automated Perimeter
NovaBone Products Launches Breakthrough Minimally Invasive Bone Graft System
Flowonix Medical, Inc. Announces First Use of Its Patient Therapy Controller (PTC)
LabStyle Innovations Closes $2.5 Million Funding To Support Global Rollout Of Dario Diabetes Management Solution
Avita Medical Proposal For US Mass Casualty Preparedness Achieves High Rating
Vention Medical Expands To Israel
Radient Technologies Inc. Releases First Quarter Results
Smart Vision Labs Names Jeff Mortensen As Vice President Of Sales
Sonendo Appoints Vice President Of Operations
H. Lundbeck A/S (LUN.CO): Experts Call For Urgent Action To Better Diagnose Severe Form Of Bipolar I Disorder, Which Is Costing Healthcare Economies Billions1,2
Healthtrust Names Fresenius Kabi AG Winner Of A 2015 Supplier Excellence Award
TSO3 Inc. (TOS) To Present At The 4th Annual Liolios Gateway Conference On September 10, 2015
Great Basin ScientificTo Present At Three Investment Conferences In September
EXACT Sciences (EXAS) To Participate In Baird Healthcare Conference
NanoPass Will Present 8 Years Of Clinical Experience With Its Micronjet600 Device In The Coming Skin Vaccination Summit 2015 Meeting